Answer
Enerzair Breezhaler should be used during pregnancy only if the expected benefit to the patient justifies potential fetal risk, as human data are insufficient to determine risk and its indacaterol component may inhibit labour.
Sources for this answer
- Enerzair BreezhalerNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 7Document updated
Sources checked